Tweet from EricTopol at November 19, 2021 at 12:01PM
First look at the only randomized trial of a booster vaccine data (Pfizer) today https://t.co/UEa1OUDvzU
95% efficacy vs symptomatic infections, consistent across all age, sex, race, ethnicity and comorbid condition subgroups
Benefit seen very early https://t.co/bSarj5263t— Eric Topol (@EricTopol)
Nov 19, 2021
from http://twitter.com/EricTopol